Vimarsana
Biggest News Aggregation in the World

Bridgewest Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bridgewest Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bridgewest Group Today - Breaking & Trending Today

Endura Technologies Appoints New CEO, and Strategic Board Members to Accelerate Growth of System-on-Chip Power Delivery Pioneer - Vimarsana News

Endura Technologies Appoints New CEO, and Strategic Board Members to Accelerate Growth of System-on-Chip Power Delivery Pioneer

SAN DIEGO, Jan. 16, 2024 /PRNewswire/ -- Endura Technologies, a pioneer in advanced power delivery solutions for System on Chip applications, announces a significant transformation in its...

Endura Technologies Appoints New CEO, and Strategic Board Members to Accelerate Growth of System-on-Chip Power Delivery Pioneer - Vimarsana News

Endura Technologies Appoints New CEO, and Strategic Board Members to Accelerate Growth of System-on-Chip Power Delivery Pioneer

/PRNewswire/ -- Endura Technologies, a pioneer in advanced power delivery solutions for System on Chip (SoC) applications, announces a significant...

Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma - Vimarsana News

Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma

Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, announced today that Cyrus K. Mirsaidi is taking the worldwide helm as CEO, including its pharmaceutical supplier division, LumaCina, and its Contract Development and Manufacturing Organization (CDMO) division, NovaCina.

Source: yahoo.com
Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion - Vimarsana News

Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion

/PRNewswire/ -- Bio4t2® received regulatory approvals to repeatedly administer patients with T cells engineered to express a chimeric antigen receptor (CAR)...

Deals in brief: Bowtie closes Series B2 round, SGX partners with BlackRock to launch new climate action fund, and more - Vimarsana News

Deals in brief: Bowtie closes Series B2 round, SGX partners with BlackRock to launch new climate action fund, and more

Bringing you the latest news briefs on fundraising activities in the Asia Pacific.